CONTROLLED-STUDY OF DTIC VERSUS DTIC PLUS EPIRUBICIN IN METASTATIC MALIGNANT-MELANOMA

被引：8

作者：

LOPEZ, M

PERNO, CF

DILAURO, L

PAPALDO, P

GANZINA, F

BARDUAGNI, A

机构：

[1] NATL CANC INST REGINA ELENA,DEPT MED,ROME,ITALY

[2] FARMITALIA CARLO ERBA,DEPT THERAPEUT RES,MILAN,ITALY

来源：

关键词：

D O I：

10.1007/BF00175384

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：319 / 322

页数：4

共 11 条

[1] BELLET RE, 1979, HUMAN MALIGNANT MELA, P325
[2] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN
BONFANTE, V
VILLANI, F
BONADONNA, G
[J]. TUMORI JOURNAL, 1982, 68 (02): : 105 - 111
[3] 4'-EPI-DOXORUBICIN, A NEW ANALOG OF DOXORUBICIN - A PRELIMINARY OVERVIEW OF PRE-CLINICAL AND CLINICAL-DATA
GANZINA, F
[J]. CANCER TREATMENT REVIEWS, 1983, 10 (01) : 1 - 22
[4] GOLDIN A, 1972, INT S ADRIAMYCIN, P64
[5] GOTTLIEB JA, 1975, CANCER CHEMOTH REP 3, V6, P271
[6] GOTTLIEB JA, 1972, CANCER-AM CANCER SOC, V30, P1632, DOI 10.1002/1097-0142(197212)30:6<1632::AID-CNCR2820300632>3.0.CO
[7] 2-S
[8] GRISWOLD DP, 1973, P AM ASSOC CANC RES, V14, P15
[9] PHASE-II STUDY OF EPIRUBICIN IN ADVANCED MALIGNANT-MELANOMA
LOPEZ, M
PERNO, CF
PAPALDO, P
DILAURO, L
GANZINA, F
BARDUAGNI, A
[J]. INVESTIGATIONAL NEW DRUGS, 1984, 2 (03) : 315 - 317
[10] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO